Venker Eric
President & Immunovant CEO
Venker Eric has filed 20 SEC Form 4 filings (63 transaction rows) across 2 companies, including ROIV, IMVT, with disclosures dating back to 2025. 20 of those filings fall inside the rolling window. Most recent filing: Aug 25, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$108.6M
reported sales (SEC code S)
Companies
2
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| ROIV | President & Immunovant CEO | Sale | 200,000 | $7.0M | Jul 30 | SEC ↗ | |
| IMVT | Chief Executive Officer | Sale | 3,092 | $119K | Jul 6 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 200,000 | $6.6M | Jun 26 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 200,000 | $6.1M | May 22 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 200,000 | $5.9M | Apr 22 | SEC ↗ | |
| IMVT | Chief Executive Officer | Sale | 14,229 | $343K | Apr 3 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 200,000 | $5.6M | Mar 19 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 200,000 | $5.3M | Feb 18 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 200,000 | $4.4M | Jan 14 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 200,000 | $4.5M | Dec 29 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 75,000 | $1.7M | Dec 29 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 200,000 | $4.2M | Dec 11 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 200,000 | $4.0M | Nov 7 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 414,683 | $7.0M | Oct 17 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 318,282 | $5.4M | Oct 17 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 118,418 | $2.0M | Oct 17 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 104,940 | $1.7M | Oct 14 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 20,727 | $337K | Oct 14 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 171,396 | $2.8M | Oct 8 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 355,161 | $5.7M | Oct 8 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 138,602 | $2.2M | Oct 8 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 683,818 | $10.2M | Sep 23 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 416,182 | $6.2M | Sep 23 | SEC ↗ | |
| ROIV | President & Immunovant CEO | Sale | 611,000 | $9.1M | Sep 23 | SEC ↗ |